We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+39.64%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
AUM
$205M
AUM Growth
+$34.3M
Cap. Flow
+$18.6M
Cap. Flow %
9.1%
Top 10 Hldgs %
96.81%
Holding
26
New
5
Increased
6
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$12.6M
2
GH icon
Guardant Health
GH
+$6.71M
3
CDNA icon
CareDx
CDNA
+$4.97M
4
NTRA icon
Natera
NTRA
+$4.83M
5
A icon
Agilent Technologies
A
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 77.85%
2 Materials 19.52%
3 Technology 1.04%
4 Financials 0.45%
5 Communication Services 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRS
1
DELISTED
Amyris Inc.
AMRS
$40M 19.52%
2,092,216
CDNA icon
2
CareDx
CDNA
$2.41B
$33.5M 16.35%
491,516
+64,016
+15% +$4.97M
NTRA icon
3
Natera
NTRA
$46.9B
$33.4M 16.31%
328,836
+44,035
+15% +$4.83M
GH icon
4
Guardant Health
GH
$21.9B
$28.3M 13.82%
185,330
+44,430
+32% +$6.71M
EXAS
5
DELISTED
Exact Sciences
EXAS
$22M 10.75%
166,957
+91,707
+122% +$12.6M
ILMN icon
6
Illumina
ILMN
$31B
$11.3M 5.52%
30,223
ADPT icon
7
Adaptive Biotechnologies
ADPT
$4.07B
$10.1M 4.95%
251,695
+43,595
+21% +$2.36M
TMO icon
8
Thermo Fisher Scientific
TMO
$227B
$8.73M 4.27%
19,133
+4,533
+31% +$2.16M
CELL
9
DELISTED
PhenomeX Inc. Common Stock
CELL
$8.24M 4.02%
163,977
-33,500
-17% -$2.28M
A icon
10
Agilent Technologies
A
$43.9B
$2.66M 1.3%
+20,938
New +$2.59M
MSFT icon
11
Microsoft
MSFT
$3.6T
$643K 0.31%
2,726
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$4.22T
$629K 0.31%
6,100
AMZN icon
13
Amazon
AMZN
$2.87T
$619K 0.3%
4,000
PHYS icon
14
Sprott Physical Gold
PHYS
$16.2B
$612K 0.3%
45,626
ADBE icon
15
Adobe
ADBE
$108B
$520K 0.25%
1,094
AAPL icon
16
Apple
AAPL
$4.62T
$489K 0.24%
4,000
NVDA icon
17
NVIDIA
NVDA
$5.27T
$484K 0.24%
36,280
CVX icon
18
Chevron
CVX
$404B
$463K 0.23%
+4,420
New +$432K
SYK icon
19
Stryker
SYK
$130B
$438K 0.21%
1,800
V icon
20
Visa
V
$682B
$383K 0.19%
1,809
HTGM
21
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$375K 0.18%
+12,416
New +$942K
ISRG icon
22
Intuitive Surgical
ISRG
$141B
$325K 0.16%
1,320
GS icon
23
Goldman Sachs
GS
$297B
$272K 0.13%
+833
New +$259K
JPM icon
24
JPMorgan Chase
JPM
$950B
$268K 0.13%
+1,762
New +$253K
TWST icon
25
Twist Bioscience
TWST
$8.93B
-73,178
Closed -$10.3M

Similar funds

Blue Water Life Science Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, Blue Water Life Science Advisors held 26 positions worth $205M, up 20% from $170M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Blue Water Life Science Advisors deployed $18.6M of net new capital in Q1 2021, opening 5 new positions and adding to 6 existing holdings. Its largest new stake was Agilent Technologies: 20,938 shares worth $2.66M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, down from 90% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was PhenomeX Inc. Common Stock, an estimated $2.28M trimmed.

  • Blue Water Life Science Advisors's largest Q1 2021 buy was Agilent Technologies: 20,938 shares worth $2.66M.
  • Blue Water Life Science Advisors added most to Exact Sciences in Q1 2021, an estimated $12.6M increase.
  • Blue Water Life Science Advisors's biggest Q1 2021 reduction was PhenomeX Inc. Common Stock, cutting an estimated $2.28M.
  • Blue Water Life Science Advisors fully exited Twist Bioscience in Q1 2021, selling an estimated $10.3M.
  • Blue Water Life Science Advisors's ten largest holdings make up 97% of its $205M portfolio in Q1 2021.
  • Blue Water Life Science Advisors opened 5 new positions and closed 2 in Q1 2021.
  • Blue Water Life Science Advisors's portfolio value rose 20% quarter-over-quarter to $205M.

Based on Blue Water Life Science Advisors's 13F filing for Q1 2021, filed 14 May 2021.